ADR,SEQ,ROUTE,MULTICONST,NONSERIOUS_SERIOUS_FATAL_NSF
1,1,SUBCUTANEOUS USE,N,S
2,1,SUBCUTANEOUS USE,N,F
3,1,SUBCUTANEOUS USE,N,S
4,1,SUBCUTANEOUS USE,N,N
5,1,SUBCUTANEOUS USE,N,S
6,1,SUBCUTANEOUS USE,N,S
